Nicolas Ansermot
Overview
Explore the profile of Nicolas Ansermot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monfort A, Cardoso E, Eap C, Ansermot N, Crettol S, Fischer Fumeaux C, et al.
Br J Clin Pharmacol
. 2024 Jul;
90(11):2849-2860.
PMID: 39030897
Aims: Sertraline is frequently prescribed for mental health conditions in both pregnant and breastfeeding women. According to the limited available data, only small amounts of sertraline are transferred into human...
2.
Hart X, Grunder G, Ansermot N, Conca A, Corruble E, Crettol S, et al.
World J Biol Psychiatry
. 2024 Jun;
25(9):451-536.
PMID: 38913780
Background: For psychotic disorders (i.e. schizophrenia), pharmacotherapy plays a key role in controlling acute and long-term symptoms. To find the optimal individual dose and dosage strategy, specialised tools are used....
3.
Ansermot N, Vathanarasa H, Ranjbar S, Gholam M, Crettol S, Vandenberghe F, et al.
Ther Drug Monit
. 2024 Jun;
PMID: 38833576
Background: Therapeutic drug monitoring (TDM) is strongly recommended for olanzapine due to its high pharmacokinetic variability. This study aimed to investigate the impact of various clinical factors on olanzapine plasma...
4.
Laaboub N, Ranjbar S, Strippoli M, Marques-Vidal P, Estoppey-Younes S, Ponte B, et al.
Eur J Nutr
. 2024 May;
63(5):1555-1564.
PMID: 38703227
Importance And Objective: Self-reported caffeine consumption has been widely used in research while it may be subject to bias. We sought to investigate the associations between self-reported caffeine consumption and...
5.
Grandjean C, Vandenberghe F, Dubath C, Sibailly G, Ansermot N, Crettol Wavre S, et al.
Rev Med Suisse
. 2023 Sep;
19(842):1707-1712.
PMID: 37728265
Antipsychotics are known to produce frequent and/or potentially serious adverse effects, including neurological, cardiovascular, metabolic and endocrine effects. The side-effects of antipsychotics vary according to their affinity for different central...
6.
Sjaarda J, Delacretaz A, Dubath C, Laaboub N, Piras M, Grosu C, et al.
Mol Psychiatry
. 2023 May;
28(6):2320-2327.
PMID: 37173452
Patients suffering from mental disorders are at high risk of developing cardiovascular diseases, leading to a reduction in life expectancy. Genetic variants can display greater influence on cardiometabolic features in...
7.
Perry B, Vandenberghe F, Garrido-Torres N, Osimo E, Piras M, Vazquez-Bourgon J, et al.
Lancet Reg Health Eur
. 2022 Aug;
22:100493.
PMID: 36039146
Background: Cardiometabolic dysfunction is common in young people with psychosis. Recently, the Psychosis Metabolic Risk Calculator (PsyMetRiC) was developed and externally validated in the UK, predicting up-to six-year risk of...
8.
Guinchat V, Ansermot N, Ing Lorenzini K, Politis D, Daali Y, Eap C, et al.
Front Psychiatry
. 2022 Jul;
13:910684.
PMID: 35815036
Loperamide is an over-the-counter antidiarrheal for which increasing cases of abuse or misuse are described. We report the onset of opioid use disorder associated with low to moderate doses of...
9.
Laaboub N, Dubath C, Ranjbar S, Sibailly G, Grosu C, Piras M, et al.
BMC Psychiatry
. 2022 Jul;
22(1):457.
PMID: 35804331
No abstract available.
10.
Laaboub N, Dubath C, Ranjbar S, Sibailly G, Grosu C, Piras M, et al.
BMC Psychiatry
. 2022 May;
22(1):342.
PMID: 35581641
Study Objectives: Insomnia disorders as well as cardiometabolic disorders are highly prevalent in the psychiatric population compared to the general population. We aimed to investigate their association and evolution over...